Understanding the Role of MyCareGorithm as a Visual Digital Platforms in Cancer Treatment Education and Patient Comprehension of Oncology Treatment Plans
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT07852949
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 100 Years
- Healthy Volunteers
- Accepted
Interventions
- Survey — OTHERA 6-item structured questionnaire with Yes/No response options, followed by one open-ended free-text question.
Study Details
The purpose of this research study is to learn if a digital communication tool can improve how well patients with head and neck cancer and their caregivers understand the disease and treatment plan after their first consultation visit with the doctor/nurse practitioner.
Key Dates
- First listed
- Oct 1, 2026
- Start date
- Mar 1, 2027
- Status verified
- Sep 2026
- Primary completion
- Dec 1, 2027
- Completion
- Dec 1, 2029
Study Design
- Enrollment
- 94 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DEVICE_FEASIBILITY
Arms
- Experimental: Patient/Caregiver: Use of MyCareGorithmFollowing use of the digital visual communication tool by the provider, patients and any accompanying caregivers will be asked to complete their surveys via REDCap. Providers will complete their survey immediately after the consultation with each participating patient, also via REDCap. Each survey requires approximately 5 minutes to complete. No follow-up surveys or repeat administrations are planned.
Primary Outcome Measure
Safety and Adverse Events (AEs) [ Time Frame: Through study completion; an average of 1 year ]
Central Contacts
- Steven J Frank, MD(713) 563-3601
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UT MD Anderson | Houston | Texas | 77030 | Steven Frank, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
Nationwide
By condition
By specialty
By research site
Related Studies
- Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical ProstatectomyPHASE3 · Recruiting · yair lotan · Dallas, Texas
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the BodyRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- International Registry for Men With Advanced Prostate Cancer (IRONMAN)Recruiting · Prostate Cancer Clinical Trials Consortium · Tuscaloosa, Alabama
- Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & SurgeryPHASE2 · Recruiting · The Methodist Hospital Research Institute · Houston, Texas